Related Experiment Videos
Novel chemoattractant peptides for human leukocytes
Yoe-Sik Bae1, Eun-Young Park, Youndong Kim
1Department of Biochemistry, College of Medicine, Medical Research Center for Cancer Molecular Therapy, Dong-A University, Busan 02-714, South Korea.
Biochemical Pharmacology
|October 18, 2003
Summary
Researchers discovered novel peptides that activate phospholipase A2 and related functions in phagocytic leukocytes. These peptides offer new tools for studying leukocyte signaling pathways and functions.
Area of Science:
- Immunology
- Cell Biology
- Biochemistry
Background:
- Phospholipase A2 (PLA2) is crucial for phagocytic cell functions.
- Understanding PLA2 regulation is key to modulating immune responses.
Purpose of the Study:
- To identify novel peptides that modulate phospholipase A2 activity and related phagocytic cell functions.
- To investigate the signaling pathways activated by these novel peptides in leukocytes.
Main Methods:
- Screening of a synthetic hexapeptide combinatorial library.
- Assays for arachidonic acid release, intracellular calcium mobilization, superoxide generation, and chemotactic migration.
- Analysis of signaling pathways including extracellular signal-regulated protein kinase (ERK) activation, phosphatidylinositol-3-kinase (PI3K), protein kinase C (PKC), and MEK.
Main Results:
- Identified 24 novel peptides stimulating arachidonic acid release and cytosolic PLA2 activity in differentiated HL60 cells.
- Peptides induced pertussis toxin-sensitive intracellular calcium release, specifically in phagocytic leukocytes.
- Stimulated superoxide generation and chemotactic migration in human neutrophils and monocytes.
- Four peptides acted as formyl peptide receptor like 1 (FPRL1) ligands; two induced calcium release independently of FPRL1.
- Four peptides activated ERK via PI3K, PKC, and MEK-dependent pathways.
Conclusions:
- Novel peptides identified provide valuable tools for studying differential signaling in leukocytes.
- These peptides modulate key phagocytic functions, offering potential therapeutic or research avenues.
- Demonstrated distinct and shared signaling pathways activated by these peptides in phagocytic cells.